ArticleFrontiers in immunology2018

IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation Blockade.

Jean Kwun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.